Terminalia chebula Retz. Fruit Extracts Inhibit Bacterial Triggers of Some Autoimmune Diseases and Potentiate the Activity of Tetracycline
- 6 Downloads
Terminalia chebula Retz. is a northern Indian plant species known for its anti-inflammatory and antimicrobial properties. T. chebula fruit powder was extracted with solvents of varying polarity and screened for bacterial growth inhibition by disc diffusion assay. The minimum inhibitory concentration (MIC) was quantified by both liquid dilution and disc diffusion techniques. To screen for combinatorial effects, the T. chebula fruit extracts were combined with a range of conventional antibiotics and tested against each bacteria using a liquid dilution assay. Where synergy was detected, the optimal ratios were determined using isobologram analysis. Toxicity was examined using Artemia nauplii and HDF bioassays. T. chebula fruit methanolic, aqueous and ethyl acetate extracts displayed strong antimicrobial activity against the bacterial triggers of all autoimmune inflammatory diseases except K. pneumoniae, for which only moderate inhibition was observed. Indeed, MIC values as low as 195 μg/mL were measured for the aqueous extract against a resistant strain of P. aeruginosa. Of further note, both the aqueous and ethyl acetate extracts interacted synergistically in combination with tetracycline against K. pneumoniae (Σ FIC 0.38 and 0.25 respectively). All extracts were nontoxic in the Artemia and HDF toxicity assays, further indicating their potential for medicinal use.
KeywordsSynergy Multi-drug resistant bacteria Combinational therapies Rheumatoid arthritis Ankylosing spondylitis Multiple sclerosis
Brine-shrimp lethality assay
Human dermal fibroblasts
Dose of sample necessary to have a lethal effect on 50% of test organisms or cells
Minimum inhibitory concentration
The sum of the fractional inhibitory concentration
We are most grateful to Dr Paran Rayan for supplying the plant materials used in this study. Financial support for this work was provided by the Environmental Futures Research Institute and the School of Natural Sciences, Griffith University, Australia.
- 2.WHO (2016) Antimicrobial resistance. World Health Organization. http://www.who.int/mediacentre/factsheets/fs194/en/. Last cited on 2017 May 10
- 4.Ilanko A, Cock IE (2018) The interactive antimicrobial activity of contentional antibiotics and Petalostigma spp. extracts against bacterial triggers of some autoimmune inflammatory diseases. BMC Complement Alt Med (in press)Google Scholar
- 5.Chowdhury AN, Ashrafuzzaman M, Ali H, Liza LN, Zinnah KMA (2013) Antimicrobial activity of some medicinal plants against multi drug resistant human pathogens. Adv Biosci Bioeng 1:1–24Google Scholar
- 13.Cock IE, Cheesman M (2018) The potential of plants of the genus Syzygium (Myrtaceae) for the prevention and treatment of arthritic and autoimmune diseases. In: Preedy VR, Watson RR (eds) Bioactive foods as dietary interventions for arthritis, osteoarthritis, and related autoimmune siseases, 2nd edn. Elsevier, NetherlandsGoogle Scholar
- 25.Shin WS (2016) Combination antibacterial therapy against β-lactam drug resistance. ProQuest Dissertations Publishing. https://conservancy.umn.edu/handle/11299/182200. Last cited on 2018 April 24
- 26.Ba XL, Harrison EM, Lovering AL, Gleadall N, Zadoks R, Parkhill J, Peacock SJ, Holden MT, Paterson GK, Holmes MA (2015) Old drugs to treat resistant bugs: methicillin-resistant Staphylococcus aureus isolates with mecC are susceptible to a combination of penicillin and clavulanic acid. Antimicrob Agents Chemother 59:7396–7404. https://doi.org/10.1128/AAC.01469-15 CrossRefPubMedPubMedCentralGoogle Scholar